EFTA00732301.pdf

From: Jeffrey Epstein <[email protected]> To: "gmaxl®instantemail.t-mobile.co.uk" <gmaxl®instantemail.t-mobile.co.uk> Subject: Fwd: Vivendi/Credit des Alpes/Pharma Date: Fri, 01 Oct 2010 16:20:32 +0000 Attachments: Agefl.pdf; Tombstone_GVT-Vivendi-Credit_des_Alpes.pdf; CLIP-0F2E5DD9.JPG talk to me Forwarded message From: Date: 2010/10/1 Subject: Vivendi/Credit des Alpes/Pharma To: [email protected] My dear Jeff, it was really good to see you in such a good shape. I look better --but you certainly great. Be serious for a minute: Following the transaction that we closed with Vivendi (mentioned at lunch and of which I am attaching a description), another European client mandated my bank Credit des Alpes to identify a possible acquisition in the pharmaceutical and/or medical appliances and/or medical devices (practically almost anything that has to do with human health) industries. What our new client really wants to buy is Ebitda growth. Ideally 20+ % pa., which is much more likely to be found in emerging economies than around here. Good target size is Ebitda $ 200-400 with little debt (ie. a transaction value of $1.5-3bn). In my experience going through the traditional channels of my competitors investment banks has never produced anything. I thought that your ideas could be of great help to me and I'd welcome your advice. I look forward to see you in New York either on the 12th or around the 21st of October. Please let me know if you'll be there. Behave, Fabrizio Cerina Financial Times. December 10, 2009 CREDIT DES ALPES, Geneva office Tel. Fax CREDIT DES ALPES, Lugano office Tel. direct Fax direct EFTA00732301 This message is intended only for the person(s) to which it is addressed and may contain privileged, confidential and/or insider information. If you have received this communication in error, please notify us immediately by replying to the message and deleting it from your computer. Any disclosure, copying, distribution, or the taking of any action concerning the contents of this message and any attachments) by anyone other than the named recipient(s) is strictly prohibited. Credit des Alpes SA To: [email protected] The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. EFTA00732302